Cian Healthcare Ltd vs Laurus Labs Limited

A side-by-side comparison of Cian Healthcare Ltd (542678) and Laurus Labs Limited (LAURUSLABS) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Laurus Labs Limited leads 542678 vs LAURUSLABS on 10 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability04
  • Growth01
  • Size & financial health13

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

0.00
P/E ratio
125.08
0.00
P/B ratio
19.74
0.00%
Dividend yield
0.10%
₹-9.32
EPS
₹16.47

Profitability

LAURUSLABS takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

-49.20%
Return on equity
16.77%
-16.00%
Return on capital
17.58%
-24.00%
EBITDA margin
26.09%
-82.14%
Net margin
13.07%

Growth

LAURUSLABS takes 1/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

-25.97%
Revenue CAGR (3Y)
4.09%
—
Profit CAGR (3Y) even
3.91%

Size & financial health

LAURUSLABS takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹0 Cr
Market cap
₹1.11L Cr
₹28 Cr
Revenue
₹6,813 Cr
₹-23 Cr
Net profit
₹890 Cr
0.00
Debt / equity
0.45
Cian Healthcare Ltd
  • + ["Company has reduced debt.", "Promoter holding has increased by 67.9% over last quarter."]
  • − ["Stock is trading at 3.92 times its book value", "Company has low interest coverage ratio.", "The company has delivered a poor sales growth of -17.4% over past five years.", "Company has a low return on equity of -18.6% over last 3 years.", "Company might be capitalizing the interest cost", "Company has high debtors of 163 days."]
Laurus Labs Limited
  • + []
  • − ["Stock is trading at 21.00 times its book value", "The company has delivered a poor sales growth of 7.2% over past five years.", "The company has delivered a poor profit growth of -2.0% over past five years."]
Cian Healthcare Ltd full analysis Laurus Labs Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.